|
|
| 
|
| 1996 Grants |
| Investigator |
Institution |
Project Title |
Grant Duration |
Amt Granted |
| Frank Arnett,
M.D. |
University of
Houston
Houston, Texas |
Candidate genes
for susceptibility to systemic sclerosis in Choctaw Native
Americans |
One Year |
$34,994 |
| Stephen Clark,
M.D. |
VA Medical Center
Newington, Conn |
Analysis of the
tight skin-2 mutation in an immune deficient mouse |
One Year |
$34,930 |
| Barry Gruber,
M.D. |
SUNY at Stony
Brook
Stony Brook, N.Y. |
Determining the
mechanism of action for pirfenidone: a new antifibrotic
agent for treatment of systemic sclerosis |
One Year |
$35,000 |
| J. Lee Nelson,
M.D. |
Fred Hutchinson
Cancer Center
Seattle, Wash. |
HLA alloantigens,
pregnancy, and risk of scleroderma |
One Year |
$35,000 |
| David Strehlow,
Ph.D. |
Boston University
Medical Center
Boston, Mass. |
Genetic markers
for hypoxia using differential display |
One Year |
$35,000 |
| Maria Trojanowska,
M.D. |
Medical University
of South Carolina
Charleston, S.C. |
TGF-B Receptor
signaling in fibrosis |
One Year |
$35,000 |
| David Wyler,
M.D. |
New England Medical
Center
Boston, Mass. |
Regulation of
fibrosin expression in scleroderma fibroblast activation.
I cloning and analysis of human fibrosin gene |
One Year |
$35,000 |
| |
|
Total Granted 1996: |
|
$244,924 |
|
| All
grants collaboratively funded by the Scleroderma Federation
and the United Scleroderma Foundation. |
Back
to Our Researchers |
|
|
|
|
